Skip to content

Organon logo

Main menu
      • Our focus
      • Products list
      • Patient support programs
      • Organon Pro for healthcare professionals
      • Safety data sheets
      • Product patents
      • Leadership team
      • Board of Directors
      • Corporate governance
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
    • Environmental, social & governance
      • Our Suppliers
      • Supplier relationship management
    • Media
    • News
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Visit Organon's Twitter Opens a new window Visit Organon's Facebook Opens a new window Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Kirke Weaver

Kirke Weaver

General Counsel and Corporate Secretary

Download bio

Download photo

Kirke serves as the senior legal adviser and is responsible for Organon’s worldwide legal affairs, compliance and global ESG and corporate responsibility functions. He is focused on ensuring the company maintains the highest ethical standards and responsible business practices, which will help drive Organon to achieve its goal to be the leading women’s healthcare company.

Prior to his appointment as General Counsel and Corporate Secretary, Kirke served as Senior Vice President, Commercial, Regulatory, Securities, Employment and Deputy Corporate Secretary at Organon. He was critical to launching Organon as a standalone company in June 2021, acting as a senior member of the legal leadership team.

Before joining Organon, Kirke was the Vice President for Regulatory Legal at Merck, known as MSD outside the U.S. Over his 18-year career there, he developed a deep expertise in the pharmaceutical industry and held positions of increasing responsibility counseling the business in areas such as litigation, regulatory, commercial, and compliance. He also led the Customer Alliances & Innovation group to develop and commercialize new software tools to support medication adherence.

Kirke has a J.D. from the Yale Law School and a B.A. in history and government from the College of William and Mary.

More of our Executive Team
View full Executive Team
Image of Kevin Ali, CEO
Kevin Ali, CEO

Image of Aaron Falcione, Chief Human Resources Officer
Aaron Falcione, Chief Human Resources Officer

Image of Joseph Morrissey, Head of Manufacturing & Supply
Joseph Morrissey, Head of Manufacturing & Supply

Image of Rachel Stahler, Chief Digital & Commercial Innovation Officer
Rachel Stahler, Chief Digital & Commercial Innovation Officer

Previous
Next

Connect with us on social

Linkedin icon Opens a new window Twitter icon Opens a new window Facebook icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Organon logo

Company

  • About us
  • Our Leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media
  • Organon Pro for healthcare professionals

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Consumer Health Data Policy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. Opens a new window TRUSTe Opens a new window

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov Opens a new window).

Decline Accept